SCHEMBL12443129

SCHEMBL12443129

O=C(N/N=C/c1ccc(Cl)cc1)c1ccncc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.89
KMT2A Q03164 6/20 0.76
MEN1 O00255 3/20 0.76
MAPT P10636 5/20 0.76
RECQL P46063 1/20 0.76
L3MBTL1 Q9Y468 3/20 0.74
MPO P05164 1/20 0.68
POLB P06746 2/20 0.66
PSMD14 O00487 1/20 0.66
THRB P10828 1/20 0.66
HPGD P15428 1/20 0.66
KDM4E B2RXH2 4/20 0.65
NPC1 O15118 3/20 0.65
MITF O75030 1/20 0.65
RAB9A P51151 1/20 0.65
GPR174 Q9BXC1 1/20 0.65
ALDH1A1 P00352 2/20 0.64
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
CA4 P22748 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13381467 0.92 MEN1 (0.88) SMN1; SMN2KMT2AMEN1MAPTRECQL
SCHEMBL28393986 0.91 MAPT (0.93) SMN1; SMN2KMT2AMEN1MAPTRECQL
SCHEMBL28389907 0.91 MAPT (0.93) SMN1; SMN2KMT2AMEN1MAPTRECQL
SCHEMBL2988108 0.89 MEN1 (0.82) SMN1; SMN2KMT2AMEN1MAPTRECQL
SCHEMBL2988105 0.89 MEN1 (0.82) SMN1; SMN2KMT2AMEN1MAPTRECQL
SCHEMBL12443153 0.86 MEN1 (1.00) SMN1; SMN2KMT2AMEN1MAPTL3MBTL1
SCHEMBL12443128 0.86 SMN1; SMN2 (0.79) SMN1; SMN2KMT2AMEN1MAPTL3MBTL1
N'-(4-Methylbenzylidene)Isonicotinohydrazide SCHEMBL12443123 0.85 L3MBTL1 (1.00) SMN1; SMN2KMT2AMEN1MAPTL3MBTL1
SCHEMBL12443125 0.85 NPC1 (0.77) SMN1; SMN2KMT2AMEN1MAPTL3MBTL1
N'-Benzylidene Isonicotinohydrazide SCHEMBL28282742 0.84 KMT2A (0.75) SMN1; SMN2KMT2AMEN1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785452-B2 Anti-infective compounds INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2014-07-22 US disclosed
US-8785452-B2 Anti-infective compounds INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2014-07-22 US disclosed
US-20110178077-A1 Anti-infective compounds INSTITUT PASTEUR KOREA (KR) 2011-07-21 US disclosed
US-20110178077-A1 Anti-infective compounds INSTITUT PASTEUR KOREA (KR) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178077-A1 Anti-infective compounds RABGGTB, ELANE, SERPINB1 SMN1; SMN2 4839/4885KMT2A 4781/4885MEN1 3685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.